Welcome to AZMedicalScience — a dedicated platform for healthcare professionals to access specialized scientific content and research.

Header Logo
  • Respiratory & Immunology
  • Cardiovascular, Renal & Metabolism
  • Oncology
  • Rare Disease

Welcome to AZMedical Science

AZMedical Science is a website developed by AstraZeneca to provide non-promotional, disease state education for healthcare professionals.

 

Please note that the content available on this website may vary depending on your location, in accordance with local regulatory requirements.

 

By clicking "Enter," you confirm that you are a licensed healthcare professional and understand the nature of this content.

I am an AstraZeneca authorized person

Exit
AstraZeneca MDT Resource Hub header banner featuring science imagery in abstract circular rings.
AstraZeneca MDT Resource Hub header banner featuring science imagery in abstract circular rings.

Welcome to the AstraZeneca MDT Resource Hub 

  • Home
  • MDT-in-a-Box
  • Rosetta
  • Future Resources

Empowering multidisciplinary teams to deliver guideline-concordant cancer care

Multidisciplinary teams (MDTs) sit at the heart of modern oncology. A well-functioning MDT can improve clinical decision quality and care coordination, contributing to better patient outcomes.1-8

AstraZeneca has developed the MDT Resource Hub to provide healthcare professionals and hospital administrators with tangible, evidence-informed resources to help establish, scale and optimise MDTs. Here, you will find practical tools, operational templates, and educational programmes that you can download and adapt for use within your hospital’s workflows. Choose the right support for your MDT today:

MDT in a Box logo with vibrant geometric emblem.
MDT in a Box logo with vibrant geometric emblem.

Build the Foundations

Access MDT-in-a-Box for practical recommendations that you can download and use to assist your hospital’s existing workflow.

ROSETTA logo.
ROSETTA logo.

Compare Decisions

Use ROSETTA to simulate patient scenarios and explore consensus across the global MDT community.

Future Resources logo.
Future Resources logo.

Expand Your Toolkit

Discover additional resources as they become available.

Contact the programme team

If you have any market-specific questions, feedback or suggestions on how we can improve our MDT offering, please email MDTSolutions@astrazeneca.com

  1. Specchia ML, et al. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res. 2020;20(1):73.
  2. Huang RS, et al. The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis. J Natl Cancer Inst. 2024;116(3):356-369.
  3. Patirelis, et al. Impact of multidisciplinary team assessment on surgical outcome of non-small cell lung cancer: a re…. Cardiothorac Surg. 2025;33:16.
  4. Berardi R, et al. Benefits and limitations of a multidisciplinary approach in cancer patient management. Cancer Manag Res. 2020;12:9363-9374.
  5. de Castro G Jr, et al. Does multidisciplinary team management improve clinical outcomes in NSCLC? A systematic review with…. JTO Clin Res Rep. 2023;4(12):100580.
  6. Srivastava A, et al. Impact of multidisciplinary team care on patient-reported outcomes in patients with lung cancer: a …. Curr Oncol. 2025;32(12):697.
  7. Stone CJ, et al. Health resource and cost savings achieved in a multidisciplinary lung cancer clinic. Curr Oncol. 2021;28(3):1681-1695.
  8. Kehl KL, et al. Tumor board participation among physicians caring for patients with lung cancer or colorectal cancer. J Oncol Pract. 2015;11(3):e267-e278.

Doc ID: Z4-89378 DOP: October 2026

Connessiallasalute.it
Connessiallasalute.it

This site is intended for healthcare professionals

 

ASTRAZENECA Z4-85831 | 8/2026 |  ©ASTRAZENECA 2025 ALL RIGHTS RESERVED

 

Cookies

Contact Us

Privacy Notice